HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ

por Rakovitch, E, Nofech-Mozes, S, Hanna, W, Narod, S, Thiruchelvam, D, Saskin, R, Spayne, J, Taylor, C, Paszat, L
Publicado 2012

Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies

por Rakovitch, E., Gray, R., Baehner, F. L., Sutradhar, R., Crager, M., Gu, S., Nofech-Mozes, S., Badve, S. S., Hanna, W., Hughes, L. L., Wood, W. C., Davidson, N. E., Paszat, L., Shak, S., Sparano, J. A., Solin, L. J.
Publicado 2018